A national security advocacy group is going up with digital advertising in Texas this week, praising Governor Greg Abbott and Texas Republicans for taking aggressive steps to remove Chinese Communist Party (CCP)-linked medical technology from the state's healthcare system.
Protecting America Initiative, which exposes CCP influence operations targeting American institutions, launched the 30-second spot titled "Tip Of The Spear" across Texas.
The ad draws a direct line from China's exploitation of the southern border to the newer threat of CCP-owned medical device companies operating inside American hospitals. "When China exploited the border crisis to threaten America, Texas stood strong on the front lines," the ad's narrator says. "Now China is using critical medical devices to infiltrate our healthcare system. And once again, the Lone Star State is at the tip of the spear."
The campaign comes on the heels of significant action from both the Abbott administration and the Texas Legislature. Governor Abbott recently ordered the Texas Health and Human Services Commission to immediately review and mitigate cybersecurity risks associated with Chinese-manufactured patient-monitoring devices, as part of a broader expansion of the state's Prohibited Technologies List to include CCP-linked hardware and software entities.
Lawmakers have also moved aggressively. A coalition of 53 Texas state legislators sent a formal letter to the state's health commission calling for a total purge of CCP-linked technology from hospital rooms. The letter outlined adopting strict cybersecurity standards to ban CCP procurement, launching a full audit of existing state contracts, and incentivizing American manufacturing to end the state's dependence on technology sourced from adversarial nations.
Federal warnings back the urgency behind those demands. The FDA and CISA have issued alerts warning that certain Chinese-made patient monitors contain built-in backdoors capable of transmitting patient vitals and private health data to overseas servers, a vulnerability that lawmakers and advocates say cannot be ignored.
The Trump administration has also weighed in at the federal level. The U.S. Department of Commerce has initiated a national security review under Section 232 of the Trade Expansion Act, examining risks posed by foreign-made medical devices and the potential for adversarial nations to weaponize their control over critical healthcare supply chains.
